Severity in irritable bowel syndrome: A rome foundation working team report

American Journal of Gastroenterology

Volumn 106, Issue 10, 2011, Pages 1749-1759

  Drossman, Douglas A ^a   Chang, L ^b   Bellamy, N ^c   Gallo Torres, H E ^d   Lembo, A ^e   Mearin, F ^f   Norton, N J ^g   Whorwell, P ^h  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF QUEENSLAND   (Australia)

^d CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^e HARVARD UNIVERSITY   (United States)

^f CENTRO MÉDICO TEKNON   (Spain)

^g International Foundation for Functional Gastrointestinal Disorders   (United States)

^h UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CENTRAL NERVOUS SYSTEM; CLINICAL DECISION MAKING; CLINICAL PRACTICE; DISABILITY; DISEASE SEVERITY; GASTROINTESTINAL SYMPTOM; HEALTH BEHAVIOR; HEALTH SURVEY; HUMAN; INTERNET; IRRITABLE COLON; ITALY; PATIENT ATTITUDE; PATIENT CARE; PHYSICIAN; PRIORITY JOURNAL; PSYCHOMETRY; QUALITY OF LIFE; SOCIAL PSYCHOLOGY; TERTIARY HEALTH CARE;

ADAPTATION, PSYCHOLOGICAL; ADVISORY COMMITTEES; CENTRAL NERVOUS SYSTEM; COMORBIDITY; DISABLED PERSONS; FOCUS GROUPS; FOUNDATIONS; HEALTH STATUS; HUMANS; INTERDISCIPLINARY COMMUNICATION; INTERNET; IRRITABLE BOWEL SYNDROME; MENTAL DISORDERS; QUALITY OF LIFE; SEVERITY OF ILLNESS INDEX; STRESS, PSYCHOLOGICAL;

EID: 80053921959     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1038/ajg.2011.201     Document Type: Article

References (41)

1. Longstreth GF, Thompson WG, Chey WD, et al. Functional Bowel Disorders. In Drossman DA, Corazziari E, Delvaux M, et al. (eds). Rome III: The Functional Gastrointestinal Disorders, 3rd edn. Degnon Associates: McLean, VA, 2006 pp. 487-555.
2. Drossman DA, Camilleri M, Mayer EA, et al. AGA Technical Review on Irritable Bowel Syndrome. Gastroenterology 2002; 123: 2108-31. (Pubitemid 35408332)
3. DeVaul RA, Faillace LA. Persistent pain and illness insistence-a medical profile of proneness to surgery. Am J Surg 1978; 135: 828-33. (Pubitemid 8377334)
4. Drossman DA, Thompson WG. The irritable bowel syndrome: review and a graduated, multicomponent treatment approach. Ann Intern Med 1992; 116: 1009-16.
5. Drossman DA, Li Z, Andruzzi E, et al. U.S. householder survey of functional gastrointestinal disorders: prevalence, sociodemography and health impact. Dig Dis Sci 1993; 38: 1569-80. (Pubitemid 23271409)
6. Lembo A, Ameen V, Drossman DA. Irritable bowel syndrome: toward an understanding of severity. Clin Gastroenterol Hepatol 2005; 3: 717-25. (Pubitemid 41116722)
7. Drossman DA, Whitehead WE, Toner BB, et al. What determines severity among patients with painful functional bowel disorders? Am J Gastroenterol 2000; 95: 974-80. (Pubitemid 30196734)
8. Drossman DA, Li Z, Leserman J, et al. Effects of coping on health outcome among female patients with gastrointestinal disorders. Psychosom Med 2000; 62: 309-17. (Pubitemid 30347074)
9. Creed F, Levy R, Bradley L, et al. Psychosocial Aspects of Functional Gastrointestinal Disorders. In Drossman DA, Corazziari E, Delvaux M, et al. (eds). Rome III: The Functional Gastrointestinal Disorders, 3rd edn. Degnon Associates: McLean, VA, 2006 pp. 295-368.
10. Sperber AD, Morris CB, Greemberg L, et al. Development of abdominal pain and IBS following gynecological surgery: a prospective, controlled study. Gastroenterology 2008; 134: 75-84. (Pubitemid 350309329)
11. Drossman DA, Li Z, Leserman J, et al. Health status by gastrointestinal diagnosis and abuse history. Gastroenterology 1996; 110: 999-1007. (Pubitemid 26113737)
12. Mayeux R, Drossman DA, Basham KK, et al. The stress response. Gulf War and Health: Physiologic, Psychologic, and Psychosocial Effects of Deployment-Related Stress, Volume 6 edn. The National Academies Press: Washington, DC, 2008 pp. 49-74.
13. Drossman DA, Li Z, Toner BB, et al. Functional bowel disorders: a multicenter comparison of health status, and development of illness severity index. Dig Dis Sci 1995; 40: 986-95.
14. Sperber AD, Carmel S, Atzmon Y, et al. Use of the Functional Bowel Disorder Severity Index (FBDSI) in a study of patients with the Irritable bowel syndrome and fibromyalgia. Am J Gastroenterol 2000; 95: 995-8. (Pubitemid 30196736)
15. Francis CY, Morris J, Whorwell PJ. The irritable bowel severity scoring system: a simple method of monitoring irritable bowel syndrome and its progress. Aliment Pharmacol Ther 1997; 11: 395-402. (Pubitemid 27183522)
16. Coffin B, Dapoigny M, Cloarec D, et al. Relationship between severity of symptoms and quality of life in 858 patients with irritable bowel syndrome. Gastroenterol Clin Biol 2004; 28: 11-5. (Pubitemid 38325597)
17. Kennedy T, Jones R, Darnley S, et al. Cognitive behaviour therapy in addition to antispasmodic treatment for irritable bowel syndrome in primary care: randomised controlled trial. BMJ 2005; 331: 435.
18. Carruthers HR, Miller V, Morris J, et al. Using art to help understand the imagery of irritable bowel syndrome and its response to hypnotherapy. Int J Clin Exp Hypn 2009; 57: 162-73.
19. Lembo AJ, Conboy L, Kelley JM, et al. A treatment trial of acupuncture in IBS patients. Am J Gastroenterol 2009; 104: 1489-97.
20. Spiegel B, Harris L, Lucak S, et al. Developing valid and reliable health utilities in irritable bowel syndrome: results from the IBS PROOF cohort. Am J Gastroenterol 2009; 104: 1984-91.
21. Spiegel B, Strickland A, Naliboff BD, et al. Predictors of patient-assessed illness severity in irritable bowel syndrome. Am J Gastroenterol 2008; 103: 2536-43.
22. van der Horst HE, Van Dulmen AM, Schellevis FG, et al. Do patients with irritable bowel syndrome in primary care really differ from outpatients with irritable bowel syndrome? Gut 1997; 41: 669-74. (Pubitemid 27496148)
23. Ricci JF, Jhingran P, Harris W, et al. Impact of differences in severity of irritable bowel syndrome (IBS) on patients'well being and resource use. Gastroenterology 2001; 120: A406.
24. Sach J, Bolus R, FitzGerald L, et al. Is there a difference between abdominal pain and discomfort in moderate to severe IBS patients? Am J Gastroenterol 2002; 97: 3131-8. (Pubitemid 35424586)
25. Hahn BA, Kirchdoerfer LJ, Fullerton S, et al. Patient-perceived severity of irritable bowel syndrome in relation to symptoms, health resource utilization and quality of life. Aliment Pharmacol Ther 1997; 11: 553-9. (Pubitemid 27286958)
26. Longstreth GF, Wilson A, Knight K, et al. Irritable bowel syndrome, health care use, and costs: a U.S. managed care perspective. Am J Gastroenterol 2003; 98: 600-7. (Pubitemid 36348532)
27. Hillila MT, Farkkila MA. Prevalence of irritable bowel syndrome according to different diagnostic criteria in a non-selected adult population. Aliment Pharmacol Ther 2004; 20: 339-45. (Pubitemid 39062137)
28. Liu JH, Chen GH, Yeh HZ, et al. Enteric-coated peppermint-oil capsules in the treatment of irritable bowel syndrome: a prospective, randomized trial. J Gastroenterol 1997; 32: 765-8.
29. Tack J, Broekaert D, Fischler B, et al. A controlled cross-over study of the selective serotonin reuptake inhibitor citalopram in irritable bowel syndrome. Gut 2006; 55: 1095-103. (Pubitemid 44085674)
30. Drossman DA, Toner BB, Whitehead WE, et al. Cognitive-behavioral therapy verses education and desipramine verses placebo for moderate to severe functional bowel disorders. Gastroenterology 2003; 125: 19-31. (Pubitemid 36799103)
31. Guthrie E, Creed F, Dawson D, et al. A controlled trial of psychological treatment for the irritable bowel syndrome. Gastroenterology 1991; 100: 450-7.
32. Whorwell PJ, Prior A, Faragher EB. Controlled trial of hypnotherapy in the treatment of severe refractory irritable bowel syndrome. Lancet 1984; 2: 1232-3.
33. Spiegel B, Camilleri M, Bolus R, et al. Psychometric evaluation of enpoints in IBS randomized controlled trials: a Rome Foundation Working Group Report. Gastroenterology 2009; 137: 1944-53.
34. US Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER), Center for Biologics Evaluation and Research (CBER), and Center for Devices and Radiological Health (CDRH). Guidance for industry patient-reported outcome measures: Use in medical product development to support labeling claims. Health Qual Life Outcomes 2006; 4: 1-32.
35. Lee OY, Mayer EA, Schmulson M, et al. Gender-related differences in IBS symptoms. Am J Gastroenterol 2001; 96: 2184-93. (Pubitemid 32660916)
36. Palsson OS, Whitehead WE, Barghout V, et al. IBS severity and healthrelated quality of life improve with age in women but not in men. Am J Gastroenterol 2003; 98: S272.
37. Lembo T, Naliboff B, Munakata J, et al. Symptoms and visceral perception in patients with pain-predominant irritable bowel syndrome. Am J Gastroenterol 1999; 94: 1320-6. (Pubitemid 29214648)
38. Dorn SD, Palsson OS, Thiwan SM, et al. Increased colonic pain sensitivity in irritable bowel syndrome is the result of an increased tendency to report pain rather than increased neurosensory sensitivity. Gut 2007; 56: 1202-9. (Pubitemid 47300419)
39. Chang L, Drossman DA. Rome Foundation Endpoints and Outcomes Conference 2009: Optimizing Clinical Trials in FGIDs. Am J Gastroenterol 2010; 105: 722-30.
40. Drossman DA, Chang L, Schneck S, et al. A focus group assessment of patient perspectives on irritable bowel syndrome and illness severity. Dig Dis Sci 2009; 54: 1532-41.
41. Drossman DA, Morris C, Schneck S, et al. International survey of patients with IBS: symptom features and their severity, health status, treatments, and risk taking to achieve clinical benefit. J Clin Gastroenterol 2009; 43: 541-50.